507
Views
60
CrossRef citations to date
0
Altmetric
Original

Effect of estrogens on skin aging and the potential role of selective estrogen receptor modulators

Pages 289-297 | Received 27 Oct 2006, Accepted 23 Feb 2007, Published online: 03 Jul 2009

References

  • Wise P M, Krajnak K M, Kashon M L. Menopause; the aging of multiple pacemakers. Science 1996; 273: 67–70
  • Gilchrest B A. Age associated changes in the skin. J Am Geriatr Soc 1982; 30: 139–142
  • Kligman A M, Kligman L H. Fitzpatrick's Dermatology in General Medicine5th edn. McGraw-Hill, New York 1999; 1: 1717–1723
  • Schmidt J B, Binder M, Macheiner W, Kainz Ch, Gitsch G, Bieglmayer Ch. Treatment of skin ageing symptoms in perimenopausal females with estrogen compounds. A pilot study. Maturitas 1994; 20: 25–30
  • Sator P G, Schmidt J B, Rabe T, Zouboulis C C. Skin aging and sex hormones in women. Clinical perspectives for intervention by hormone replacement therapy. Exp Dermatol 2004; 13(Suppl 4)36–40
  • Pierard G E, Letawe C, Dowlati A, Pierard-Franchimont C. Effect of hormone replacement therapy for menopause on the mechanical properties of skin. J Am Geriatr Soc 1995; 43: 662–665
  • Pierard-Franchimont C, Letawe C, Goffin V, Pierard G E. Skin water-holding capacity and transdermal estrogen therapy for menopause: a pilot study. Maturitas 1995; 22: 151–154
  • Snell R S, Turner R. Skin pigmentation in relation to menstrual cycle. J Invest Dermatol 1966; 47: 147–155
  • Harvell J, Hussona Saeed I, Maibach H I. Changes in transepidermal water loss and cutaneous blood flow during the menstrual cycle. Contact Dermatatis 1992; 275: 294–301
  • Hall G K, Phillips T J. Skin and hormone therapy. Clin Obstet Gynecol 2004; 47: 437–449
  • Thornton M J. Oestrogen functions in skin and skin appendages. Expert Opin Ther Targets 2005; 9: 617–629
  • Albright F, Smith P H, Richardson A. Postmenopausal osteoporosis – its clinical features. JAMA 1941; 116: 2465–2474
  • Brincat M, Kabalan S, Studd J W, Moniz C F, de Trafford J, Montgomery J A. Study of the decrease of skin collagen content, skin thickness, and the bone mass in the postmenopausal women. Obstet Gynecol 1987; 70: 840–845
  • Affinito P, Palomba S, Sorrentino C, et al. Effects of postmenopausal hypoestrogenism on skin collagen. Maturitas 1999; 33: 239–247
  • Castelo-Branco C, Duran M, Gonzales-Merlo J. Skin collagen and bone changes related to age and hormone replacement therapy. Maturitas 1992; 14: 113–119
  • Callens A, Vaillant L, Lecomte P, et al. Does hormonal skin aging exist? A study of the influence of different hormone therapy regimens on the skin of postmenopausal women using non-invasive measurement techniques. Dermatology 1996; 193: 289–294
  • Maheux R, Naud F, Rioux M, et al. A randomized, double-blind, placebo-controlled study on the effect of conjugated estrogens on skin thickness. Am J Obstet Gynecol 1994; 170: 642–649
  • Sauerbronn A VD, Fonseca A M, Bagnoli V R, Saldiva P H, Pinotti J A. The effects of systemic hormone replacement therapy on the skin of the postmenopausal women. Int J Gynecol Obstet 2000; 68: 35–41
  • Varila E, Rantala I, Oikarinen A, et al. The effect of topical oestradiol on skin collagen of postmenopausal women. Br J Obstet Gynaecol 1995; 102: 985–989
  • Madison K C. Barrier function of the skin: “la raison d'etre” of the epidermis. J Invest Dermatol 2003; 121: 231–241
  • Holbrook K A, Wolff K. Fitzpatrick's Dermatology in General Medicine3rd edn. McGraw-Hill, New York 1987; 93–131
  • Dunn L, Damesyn M, Moore A, Reuben D B, Greendale G A. Does estrogen prevent skin aging? Results from the First National Health and Nutritional Examination Survey. Arch Dermatol 1997; 133: 339–342
  • Denda M, Koyama J, Hori J, et al. Age- and sex-dependent change in stratum corneum sphingolipids. Arch Dermatol Res 1993; 285: 415–417
  • Grosman N, Hvidberg E, Schou J. The effect of oestrogenic treatment on the acid mucopolysaccharide pattern in skin of mice. Acta Pharmacol Toxicol 1971; 30: 458–464
  • Danforth D N, Veis A, Breen M, Weinstein H G, Buckingham J C, Manalo P. The effect of pregnancy and labor on the human cervix: changes in collagen, glycoproteins, and glycoaminoglycans. Am J Obstet Gynecol 1974; 120: 641–651
  • Bosset S, Barre P, Chalon A, et al. Skin ageing: clinical and histopathologic study of permanent and reducible wrinkles. Eur J Dermatol 2002; 12: 247–252
  • Creidi P, Faivre B, Agache P, Richard E, Haudiquet V, Sauvanet J P. Effect of a conjugated oestrogen (Premarin) cream on ageing facial skin. A comparative study with a placebo cream. Maturitas 1994; 19: 211–223
  • Sumino H, Ichikawa S, Abe M, et al. Effects of aging and postmenopausal hypoestrogenism on skin elasticity and bone mineral density in Japanese women. Endocrine J 2004; 51: 159–164
  • Punnonen R, Vaajalahti P, Teisala K. Local estriol treatment improves the structure of elastic fibers in the skin of postmenopausal women. Ann Chir Gynaecol 1987; 202(Suppl)39–41
  • Muller-Rover S, Handjiski B, Van der Veen C, et al. Comprehensive guide to the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol 2001; 117: 3–15
  • Lynfield Y L. Effect of pregnancy on the human hair cycle. J Invest Dermatol 1960; 35: 323–327
  • Whiting D A. Diagnosis of Alopecia. Current Concepts. A scope Pub Upjohn Co., Kalamazoo 1990
  • Rebora A. Pathogenesis of androgenetic alopecia. Am Acad Dermatol 2004; 50: 77–79
  • Ekoe J M, Burckhardt P, Ruedi B. Treatment of hirsutism, acne and alopecia with cyproterone acetate. Dermatologica 1980; 160: 398–404
  • Hoffmann R, Happle R. Finasteride is the main inhibitor of 5 alpha-reductase activity in microdissected dermal papillae of human hair follicles. Arch Dermatol Res 1999; 291: 100–103
  • Schuhmacher-Stock U. Estrogen treatment of hair diseases. Hair Research, C E Orfanos, W Montagna, G Stüttgen. Springer-Verlag, Berlin 1981
  • Orfanos C E, Vogels L. Lokaltherapie der Alopecia androgenetica mit 17alpha-Oestradiol: eine kontrollierte randomisierte Doppelblindstudie. Dermatologica 1980; 161: 124–132
  • Niiyama R, Happle R, Hoffmann R. Influence of estrogens on the androgen metabolism in different subunits of human hair follicles. Eur J Dermatol 2001; 11: 165–168
  • Couse J F, Lindzey J, Grandien K, Gustafsson J A, Korach K S. Tissue distribution and quantitative analysis of estrogen receptor-alpha (ER alpha) and estrogen receptor beta (ER beta) messenger ribonucleic acid in the wild-type and ER-alpha-knockout mouse. Endocrinology 1997; 138: 4616–4621
  • Pappas T C, Gametchu B, Yannariello-Brown J, Collins T J, Watson C S. Membrane estrogen receptors identified by multiple antibody labeling and impeded ligand binding. FASEB 1995; J9: 404–441
  • Thornton M J, Taylor A H, Mulligan K, et al. Oestrogen receptor beta is the predominant oestrogen receptor in human scalp skin. Exp Dermatol 2003; 12: 181–190
  • Verdier-Sevrain S, Yaar M, Cantatore J, Traish A, Gilchrest B A. Estradiol induces proliferation of keratinocytes via receptor-mediated mechanisms. FASEB J 2004; 11: 1252–1254
  • Rossouw J E, Anderson Gl, Prentice R L, et al. Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321–333
  • Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998; 280: 605–613
  • Burger H, Archer D, Barlow D, et al. Practical recommendations for hormone replacement therapy in the peri- and postmenopause. Climacteric 2004; 7: 1–7
  • Speroff L, Kenemans P, Burger H G. Practical guidelines for postmenopausal hormone therapy. Maturitas 2005; 51: 4–7
  • Gambacciani M, Genazzani A R. Hormone replacement therapy: the benefits in tailoring the regimen and dose. Maturitas 2001; 40: 195–201
  • Burger H. Hormone replacement therapy in the post-Women's Health Initiative era. Report of a meeting held in Funchal, Madeira, February 24 – 25. Climacteric 2003; 6(Suppl 1)11–36
  • Stevenson J. HRT, osteoporosis and regulatory authorities: Quis custodiet ipsos custodes?. Hum Reprod 2006; 21: 1668–1671
  • Sator P G, Schmidt J B, Sator M O, Huber J C, Honigsmann H. The influence of hormone replacement therapy on skin ageing. A pilot study. Maturitas 2001; 39: 43–45
  • Santen R J, Pinkerton J V, Conaway M, et al. Treatment of urogenital atrophy with low-dose estradiol: preliminary results. Menopause 2002; 9: 179–187
  • Hejlova P, Zivny J. Effect of vaginal estriol on urogenital symptoms in postmenopausal women. Ceska Gynekol 2004; 69: 329–335
  • Kurzer M S, Xu X. Dietary phytoestrogens. Annu Rev Nutr 1997; 17: 353–381
  • Makela S, Santti R, Salo L, McLachlan J A. Phytoestrogens are partial estrogen agonists in the adult male mouse. Environ Health Perspect 1995; 103: 123–127
  • Bowers J L, Tyulmenkov V V, Jernigan S C, Klinge C M. Resveratrol acts as a mixed agonist/antagonist for estrogen receptor alpha and beta. Endocrinology 2000; 141: 3657–3667
  • Wei H, Saladi R, Lu Y, et al. Isoflavone genistein: photoprotection and clinical implications in dermatology. J Nutr 2003; 133: 3811S–3819S
  • Miyazaki K, Hanamizu T, Iizuka R, Chiba K. Genistein and daidzein stimulate hyaluronic acid production in transformed human keratinocyte culture and hairless mouse skin. Skin Pharmacol Appl Skin Physiol 2002; 15: 175–183
  • Bayerl C, Keil D. Isoflavonoide in der Behandlung der Hautalterung postmenopausaler Frauen. Akt Dermatol 2002; 28: 14–18
  • Ettinger B, Black D M, Mitlak B H, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 1999; 282: 637–645
  • Cummings S R, Eckert S, Krueger K A, Grady D, Powles T J, Cauley J A. The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. JAMA 1999; 281: 2189–2197
  • Delmas P D, Bjarnason N H, Mitlak B H, et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med 1997; 337: 1641–1647
  • Surazynski A, Jarzabek K, Haczynski J, Laudanski P, Palka J, Wolczynski S. Differential effects of estradiol and raloxifene on collagen biosynthesis in cultured human skin fibroblasts. Int J Molecular Med 2003; 12: 803–809

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.